<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13D" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <headerData>
    <submissionType>SCHEDULE 13D/A</submissionType>
    <previousAccessionNumber>0001193125-21-046616</previousAccessionNumber>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001695076</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>3</amendmentNo>
      <securitiesClassTitle>Common Stock, $0.00001 par value</securitiesClassTitle>
      <dateOfEvent>02/05/2026</dateOfEvent>
      <previouslyFiledFlag>false</previouslyFiledFlag>
      <issuerInfo>
        <issuerCIK>0001641281</issuerCIK>
        <issuerCUSIP>097702203</issuerCUSIP>
        <issuerName>Bolt Biotherapeutics, Inc.</issuerName>
        <address>
          <street1 xmlns="http://www.sec.gov/edgar/common">900 Chesapeake Drive</street1>
          <city xmlns="http://www.sec.gov/edgar/common">Redwood City</city>
          <stateOrCountry xmlns="http://www.sec.gov/edgar/common">CA</stateOrCountry>
          <zipCode xmlns="http://www.sec.gov/edgar/common">94063</zipCode>
        </address>
      </issuerInfo>
      <authorizedPersons>
        <notificationInfo>
          <personName>Robert Hopfner</personName>
          <personPhoneNum>(415) 697-1002</personPhoneNum>
          <personAddress>
            <street1 xmlns="http://www.sec.gov/edgar/common">Pivotal bioVenture Partners Fund I UGP</street1>
            <street2 xmlns="http://www.sec.gov/edgar/common">501 2nd Street, Suite 200</street2>
            <city xmlns="http://www.sec.gov/edgar/common">San Francisco</city>
            <stateOrCountry xmlns="http://www.sec.gov/edgar/common">CA</stateOrCountry>
            <zipCode xmlns="http://www.sec.gov/edgar/common">94107</zipCode>
          </personAddress>
        </notificationInfo>
        <notificationInfo>
          <personName>Louis Rambo</personName>
          <personPhoneNum>(202) 416-6800</personPhoneNum>
          <personAddress>
            <street1 xmlns="http://www.sec.gov/edgar/common">Proskauer Rose, LLP</street1>
            <street2 xmlns="http://www.sec.gov/edgar/common">1001 Pennsylvania Avenue NW, Suite 600</street2>
            <city xmlns="http://www.sec.gov/edgar/common">Washington</city>
            <stateOrCountry xmlns="http://www.sec.gov/edgar/common">DC</stateOrCountry>
            <zipCode xmlns="http://www.sec.gov/edgar/common">20004-2533</zipCode>
          </personAddress>
        </notificationInfo>
      </authorizedPersons>
    </coverPageHeader>
    <reportingPersons>
      <reportingPersonInfo>
        <reportingPersonCIK>0001782539</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Nan Fung Group Holdings Limited</reportingPersonName>
        <memberOfGroup>b</memberOfGroup>
        <fundType>AF</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>D8</citizenshipOrOrganization>
        <soleVotingPower>0</soleVotingPower>
        <sharedVotingPower>128119</sharedVotingPower>
        <soleDispositivePower>0</soleDispositivePower>
        <sharedDispositivePower>128119</sharedDispositivePower>
        <aggregateAmountOwned>128119</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>6.7</percentOfClass>
        <typeOfReportingPerson>CO</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonNoCIK>Y</reportingPersonNoCIK>
        <reportingPersonName>NF Investment Holdings Limited</reportingPersonName>
        <memberOfGroup>b</memberOfGroup>
        <fundType>AF</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>D8</citizenshipOrOrganization>
        <soleVotingPower>0</soleVotingPower>
        <sharedVotingPower>128119</sharedVotingPower>
        <soleDispositivePower>0</soleDispositivePower>
        <sharedDispositivePower>128119</sharedDispositivePower>
        <aggregateAmountOwned>128119</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>6.7</percentOfClass>
        <typeOfReportingPerson>CO</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonCIK>0001695076</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Pivotal bioVenture Partners Fund I, L.P.</reportingPersonName>
        <memberOfGroup>b</memberOfGroup>
        <fundType>WC</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>E9</citizenshipOrOrganization>
        <soleVotingPower>0</soleVotingPower>
        <sharedVotingPower>78445</sharedVotingPower>
        <soleDispositivePower>0</soleDispositivePower>
        <sharedDispositivePower>78445</sharedDispositivePower>
        <aggregateAmountOwned>78445</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>4.1</percentOfClass>
        <typeOfReportingPerson>PN</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonCIK>0001752862</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Pivotal bioVenture Partners Fund I G.P., L.P.</reportingPersonName>
        <memberOfGroup>b</memberOfGroup>
        <fundType>AF</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>E9</citizenshipOrOrganization>
        <soleVotingPower>0</soleVotingPower>
        <sharedVotingPower>78445</sharedVotingPower>
        <soleDispositivePower>0</soleDispositivePower>
        <sharedDispositivePower>78445</sharedDispositivePower>
        <aggregateAmountOwned>78445</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>4.1</percentOfClass>
        <typeOfReportingPerson>PN</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonNoCIK>Y</reportingPersonNoCIK>
        <reportingPersonName>Pivotal bioVenture Partners Fund I U.G.P. Ltd.</reportingPersonName>
        <memberOfGroup>b</memberOfGroup>
        <fundType>AF</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>E9</citizenshipOrOrganization>
        <soleVotingPower>0</soleVotingPower>
        <sharedVotingPower>78445</sharedVotingPower>
        <soleDispositivePower>0</soleDispositivePower>
        <sharedDispositivePower>78445</sharedDispositivePower>
        <aggregateAmountOwned>78445</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>4.1</percentOfClass>
        <typeOfReportingPerson>CO</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonNoCIK>Y</reportingPersonNoCIK>
        <reportingPersonName>Pivotal Partners Ltd</reportingPersonName>
        <memberOfGroup>b</memberOfGroup>
        <fundType>AF</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>E9</citizenshipOrOrganization>
        <soleVotingPower>0</soleVotingPower>
        <sharedVotingPower>78445</sharedVotingPower>
        <soleDispositivePower>0</soleDispositivePower>
        <sharedDispositivePower>78445</sharedDispositivePower>
        <aggregateAmountOwned>78445</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>4.1</percentOfClass>
        <typeOfReportingPerson>CO</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonNoCIK>Y</reportingPersonNoCIK>
        <reportingPersonName>Pivotal Life Sciences Holdings Limited</reportingPersonName>
        <memberOfGroup>b</memberOfGroup>
        <fundType>AF</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>E9</citizenshipOrOrganization>
        <soleVotingPower>0</soleVotingPower>
        <sharedVotingPower>78445</sharedVotingPower>
        <soleDispositivePower>0</soleDispositivePower>
        <sharedDispositivePower>78445</sharedDispositivePower>
        <aggregateAmountOwned>78445</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>4.1</percentOfClass>
        <typeOfReportingPerson>CO</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonNoCIK>Y</reportingPersonNoCIK>
        <reportingPersonName>Nan Fung Life Sciences Holdings Limited</reportingPersonName>
        <memberOfGroup>b</memberOfGroup>
        <fundType>AF</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>D8</citizenshipOrOrganization>
        <soleVotingPower>0</soleVotingPower>
        <sharedVotingPower>123119</sharedVotingPower>
        <soleDispositivePower>0</soleDispositivePower>
        <sharedDispositivePower>123119</sharedDispositivePower>
        <aggregateAmountOwned>123119</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>6.4</percentOfClass>
        <typeOfReportingPerson>CO</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonNoCIK>Y</reportingPersonNoCIK>
        <reportingPersonName>Permwell Management Limited</reportingPersonName>
        <memberOfGroup>b</memberOfGroup>
        <fundType>WC</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>E9</citizenshipOrOrganization>
        <soleVotingPower>0</soleVotingPower>
        <sharedVotingPower>5000</sharedVotingPower>
        <soleDispositivePower>0</soleDispositivePower>
        <sharedDispositivePower>5000</sharedDispositivePower>
        <aggregateAmountOwned>5000</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>0.3</percentOfClass>
        <typeOfReportingPerson>CO</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonNoCIK>Y</reportingPersonNoCIK>
        <reportingPersonName>NFLS Beta Limited</reportingPersonName>
        <memberOfGroup>b</memberOfGroup>
        <fundType>WC</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>D8</citizenshipOrOrganization>
        <soleVotingPower>0</soleVotingPower>
        <sharedVotingPower>44674</sharedVotingPower>
        <soleDispositivePower>0</soleDispositivePower>
        <sharedDispositivePower>44674</sharedDispositivePower>
        <aggregateAmountOwned>44674</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>2.3</percentOfClass>
        <typeOfReportingPerson>CO</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonNoCIK>Y</reportingPersonNoCIK>
        <reportingPersonName>NFLS Platform Holdings Limited</reportingPersonName>
        <memberOfGroup>b</memberOfGroup>
        <fundType>WC</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>E9</citizenshipOrOrganization>
        <soleVotingPower>0</soleVotingPower>
        <sharedVotingPower>44674</sharedVotingPower>
        <soleDispositivePower>0</soleDispositivePower>
        <sharedDispositivePower>44674</sharedDispositivePower>
        <aggregateAmountOwned>44674</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>2.3</percentOfClass>
        <typeOfReportingPerson>CO</typeOfReportingPerson>
      </reportingPersonInfo>
    </reportingPersons>
    <items1To7>
      <item1>
        <securityTitle>Common Stock, $0.00001 par value</securityTitle>
        <issuerName>Bolt Biotherapeutics, Inc.</issuerName>
        <issuerPrincipalAddress>
          <street1 xmlns="http://www.sec.gov/edgar/common">900 Chesapeake Drive</street1>
          <city xmlns="http://www.sec.gov/edgar/common">Redwood City</city>
          <stateOrCountry xmlns="http://www.sec.gov/edgar/common">CA</stateOrCountry>
          <zipCode xmlns="http://www.sec.gov/edgar/common">94063</zipCode>
        </issuerPrincipalAddress>
      </item1>
      <item5>
        <percentageOfClassSecurities>Items 5(a)-(c) of the Schedule 13D are amended and restated as follows:

The information set forth in rows 11 and 13 of the cover pages to this Schedule 13D is incorporated by reference. The percentage set forth in row 13 is based on 1,919,441 outstanding shares of Common Stock, as reported by the Issuer in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 12, 2025.

In addition, Mr. Kam Chung Leung directly owns 8,684 shares of Common Stock.</percentageOfClassSecurities>
        <numberOfShares>The information set forth in rows 7 through 10 of the cover pages to this Schedule 13D is incorporated by reference.</numberOfShares>
        <transactionDesc>Except as set forth on Schedule A, which is incorporated into this Item 5(c) by reference, no Reporting Person has effected any transaction in shares of Common Stock in the past sixty days.</transactionDesc>
      </item5>
    </items1To7>
    <signatureInfo>
      <signaturePerson>
        <signatureReportingPerson>Nan Fung Group Holdings Limited</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Tang Chun Wai Nelson</signature>
          <title>Tang Chun Wai Nelson, Director</title>
          <date>02/17/2026</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>NF Investment Holdings Limited</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Tang Chun Wai Nelson</signature>
          <title>Tang Chun Wai Nelson, Director</title>
          <date>02/17/2026</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Pivotal bioVenture Partners Fund I, L.P.</signatureReportingPerson>
        <signatureDetails>
          <signature>By Pivotal bioVenture Partners Fund I G.P., L.P.</signature>
          <title>its General Partner</title>
          <date>02/17/2026</date>
        </signatureDetails>
        <signatureDetails>
          <signature>By Pivotal bioVenture Partners Fund I U.G.P., Ltd.</signature>
          <title>its General Partner</title>
          <date>02/17/2026</date>
        </signatureDetails>
        <signatureDetails>
          <signature>/s/ Robert Hopfner</signature>
          <title>Robert Hopfner, Authorized Signatory</title>
          <date>02/17/2026</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Pivotal bioVenture Partners Fund I G.P., L.P.</signatureReportingPerson>
        <signatureDetails>
          <signature>By Pivotal bioVenture Partners Fund I U.G.P., Ltd.</signature>
          <title>its General Partner</title>
          <date>02/17/2026</date>
        </signatureDetails>
        <signatureDetails>
          <signature>/s/ Robert Hopfner</signature>
          <title>Robert Hopfner, Authorized Signatory</title>
          <date>02/17/2026</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Pivotal bioVenture Partners Fund I U.G.P. Ltd.</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Robert Hopfner</signature>
          <title>Robert Hopfner, Authorized Signatory</title>
          <date>02/17/2026</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Pivotal Partners Ltd</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Sun Xintong</signature>
          <title>Sun Xintong, Director</title>
          <date>02/17/2026</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Pivotal Life Sciences Holdings Limited</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Sun Xintong</signature>
          <title>Sun Xintong, Director</title>
          <date>02/17/2026</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Nan Fung Life Sciences Holdings Limited</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Sun Xintong</signature>
          <title>Sun Xintong, Director</title>
          <date>02/17/2026</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Permwell Management Limited</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Tang Chun Wai Nelson</signature>
          <title>Tang Chun Wai Nelson, Director</title>
          <date>02/17/2026</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>NFLS Beta Limited</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Sun Xintong</signature>
          <title>Sun Xintong, Director</title>
          <date>02/17/2026</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>NFLS Platform Holdings Limited</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Sun Xintong</signature>
          <title>Sun Xintong, Director</title>
          <date>02/17/2026</date>
        </signatureDetails>
      </signaturePerson>
    </signatureInfo>
  </formData>

</edgarSubmission>
